Wakefulness drug modafinil tied to fetal harm, Health Canada warns
Women who are pregnant or may become pregnant should avoid the wakefulness-promoting drug modafinil, sold as Alertec, to prevent serious harm to the fetus, Health Canada warns. (Source: CBC | Health)
Source: CBC | Health - June 20, 2019 Category: Consumer Health News Tags: News/Health Source Type: news
Modafinil Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 19, 2019 Category: Drugs & Pharmacology Source Type: news
modafinil (Provigil)
Title: modafinil (Provigil)Category: MedicationsCreated: 5/24/2002 12:00:00 AMLast Editorial Review: 2/28/2019 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - February 28, 2019 Category: Sleep Medicine Source Type: news
Nootropics, or ‘Smart Drugs,’ Are Gaining Popularity. But Should You Take Them?
The idea that a pill can supersize human intelligence is decidedly science fiction. But plenty of real-world researchers and drug-makers are working to develop nootropics: pills, supplements and other substances designed to improve various aspects of cognition.
A rough translation for the word “nootropic” comes from the Greek for “to bend or shape the mind.” And already, there are dozens of over-the-counter (OTC) products—many of which are sold widely online or in stores—that claim to boost creativity, memory, decision-making or other high-level brain functions. Some of the most popular ...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Drugs Source Type: news
Sleep Disorder Drug May Be Effective for Stimulant Abuse Sleep Disorder Drug May Be Effective for Stimulant Abuse
Modafinil, a wakefulness-promoting agent approved for narcolepsy, obstructive sleep apnea, and shift work sleep disorder, shows promise in treating stimulant use disorders.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Why are so many women taking brain boosting pills at work?
A recent study found at least one in twelve adults have taken smart drugs such as modafinil. Jess Robinson, 30, who works as an IT analyst revealed how taking smart pills have impacted her career. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2018 Category: Consumer Health News Source Type: news
Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
The researchers compared seven ADHD drugs -- amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil -- and a placebo over 12 weeks of treatment. (Source: WebMD Health)
Source: WebMD Health - August 8, 2018 Category: Consumer Health News Source Type: news
Unnecessary And Accidental Use Of ADHD Drugs Increases Over 60%, Study Suggests
(CNN) — Exposure to common medications used to treat attention deficit hyperactivity disorder has increased by more than 60% in US children and adolescents, according to a new study.
The study, published Monday in the journal Pediatrics, looked at all calls to US poison control centers for unintentional or intentional exposure to ADHD medications between 2000 and 2014 among children and adolescents. The researchers found that the number of calls increased from 7,018 in 2000 to 11,486 in 2014 — a 64% increase.
According to the study’s authors, “exposure” refers to the unnecessary ingestion, inh...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 21, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health ADHD Local TV Source Type: news
Adventures in brain-hacking: how an electrical stimulator boosted my IQ
From the smart drug modafinil to oxygen chambers, interest in cognitive enhancement is growing. But can it actually make you cleverer? I tried to find outPeople have always sought advantages over their rivals. But trying to improve intelligence as a way to do it has been off-limits. An education can be bought, but ability? You either had it or you didn ’t. Now a new science called cognitive enhancement promises that someone who doesn’t have intelligence today could have it tomorrow.Using science to boost intelligence might sound far-fetched, but some people in high places take the prospect very seriously indeed. In the...
Source: Guardian Unlimited Science - February 7, 2018 Category: Science Authors: David Adam Tags: Health & wellbeing Memory Science Technology Defence policy Drugs Drugs in sport Drugs policy Source Type: news
Nearly 2,000 Pa. consumers to get a share of $3M biopharm firm settlement
Nearly 2,000 Pennsylvania consumers will receive a share of a $3 million settlement the state negotiated with Chester County biopharmaceutical company Cephalon Inc..
The Cephalon settlement, entered into by a coalition of 47 attorneys general, resolves claims that the company violated antitrust and consumer protection laws by delaying the entry of lower-cost generic versions of Provigil into the marketplace, and that the company made misrepresentations to the U.S. Patent& Trademark Office.
Provigil… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 26, 2018 Category: Biotechnology Authors: John George Source Type: news
Nearly 2,000 Pa. consumers to get a share of $3M biopharm firm settlement
Nearly 2,000 Pennsylvania consumers will receive a share of a $3 million settlement the state negotiated with Chester County biopharmaceutical company Cephalon Inc..
The Cephalon settlement, entered into by a coalition of 47 attorneys general, resolves claims that the company violated antitrust and consumer protection laws by delaying the entry of lower-cost generic versions of Provigil into the marketplace, and that the company made misrepresentations to the U.S. Patent& Trademark Office.
Provigil… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 26, 2018 Category: American Health Authors: John George Source Type: news
EU antitrust officials charge Teva in ‘ pay-for-delay ’ deal
Antitrust regulators in the European Union charged Teva Pharmaceuticals (NYSE:TEVA) today, accusing the company of arranging an illegal deal with Cephalon to delay the sale of a cheap generic version to Cephalon’s sleep disorder drug, modafinil.
The EU competition officials have unleashed a series of fines against an array of companies in recent years over similar deals, including U.S. giant Johnson & Johnson (NYSE:JNJ).
Get the full story at our sister site, Drug Delivery Business News.
The post EU antitrust officials charge Teva in ‘pay-for-delay’ deal appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Legal News Pharmaceuticals Wall Street Beat cephalon johnsonandjohnson Teva Pharmaceuticals Source Type: news
Sun Pharma enters settlement in antitrust litigation in US
"Sun Pharmaceutical Industries Ltd, and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in re Modafinil Antitrust Litigation." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 7, 2017 Category: Pharmaceuticals Source Type: news
Provigil (Modafinil) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 3, 2017 Category: Drugs & Pharmacology Source Type: news
